MASIMO CORP

Electromedical & Electrotherapeutic Apparatus·IRVINE, CA·FY end 01/02·CIK 937556

Financials

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$1.5B	$2.1B	$2.0B	$2.0B	$327.6M
Gross Profit	$945.2M	$1.0B	$1.0B	$1.1B	$214.9M
Operating Income	$310.0M	-$266.7M	$136.5M	$210.0M	$77.4M
Net Income	-$151.5M	-$304.9M	$81.5M	—	$68.3M
Operating CF	$217.8M	$196.4M	$94.1M	$29.4M	$264.8M
Capex	$19.4M	$20.0M	$44.0M	$52.8M	$25.5M
Free Cash Flow	$198.4M	$176.4M	$50.1M	-$23.4M	$239.3M
Buybacks	$363.7M	$0	$0	$401.5M	$128.9M
Dividends	—	—	—	—	—	—

Gross Margin	61.9%	48.0%	49.0%	52.0%	65.6%
Operating Margin	20.3%	-12.7%	6.7%	10.3%	23.6%
Net Margin	-9.9%	-14.6%	4.0%	—	20.8%
FCF Margin	13.0%	8.4%	2.4%	-1.1%	73.0%
R&D / Revenue	8.3%	10.6%	8.6%	9.4%	41.9%
Effective Tax	23.8%	0.1%	7.5%	25.8%	16.3%
Debt / Equity	1.45	1.42	1.30	1.42	—
Buybacks / FCF	183.3%	0.0%	0.0%	-1715.8%	53.9%

No SIC peers ingested yet. As more companies in this industry are processed, this card will surface ratio / comp / margin comparisons.